Last reviewed · How we verify
NCT05071092
Dietary Intervention to Improve Health of Cardiovascular Patients
NA trial testing Dietary counselling in Cardiovascular Diseases in 124 participants. Completed in 5 February 2024.
5 February 2024
Quick facts
| Lead sponsor | Wageningen University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 124 |
| Start date | 28 May 2021 |
| Primary completion | 5 February 2024 |
| Estimated completion | 5 February 2024 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Dietary counselling
Conditions studied
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Heart Diseases — all drugs for Heart Diseases →
- Vascular Diseases — all drugs for Vascular Diseases →
Sponsor
Wageningen University
Who can join
18 and older, any sex, with Cardiovascular Diseases or Heart Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Voed je Beter is a randomized, multicenter, controlled trial to examine whether personalized guidance to increase adherence to the Dutch dietary guidelines, compared to usual care, improves health of cardiovascular patients who receive regular medical treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effects of 6 months dietary counseling on diet quality and cardiovascular risk profile in patients with cardiovascular disease: A randomized controlled trial.
van Damme I, van Veldhuisen ER, Verkaar AJCF, Bemelmans RHH, et al · · 2025 · cited 1× · PMID 39798221 · DOI 10.1016/j.clnu.2024.12.020
Verify or expand the search:
- PubMed search for NCT05071092
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Diseases
Currently open trials in the same condition.
- NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
- NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Wageningen University trials
Trials by the same sponsor.
- NCT07361406 — SweetSpot - The Effect of Non-nutritive Sweeteners on Health · NA · recruiting
- NCT07421466 — Umami Taste Intensity and Meal Intake · NA · completed
- NCT07075991 — Uptake and Excretion of a Single Dose of Oral 14C-labelled Polystyrene Microplastics in Healthy Volunteers · NA · completed
- NCT07059117 — Umami Taste Intensity and ad Libitum Meal Intake · NA · completed
- NCT06750497 — Forearm Immobilization in T2D · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05071092 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wageningen University
- Last refreshed: 11 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05071092.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing